Literature DB >> 22504606

Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.

Jeffrey D Stanaway1, Anna Wald, Emily T Martin, Sami L Gottlieb, Amalia S Magaret.   

Abstract

BACKGROUND: Although growing evidence suggests that condoms offer moderate protection against herpes simplex virus type 2 (HSV-2), inability to control for unknown or unmeasured confounders associated with sexual activity may reduce the accuracy of the estimates. The case-crossover design offers increased control of individual-level confounders, and was thus used with the aim of producing a more accurate estimate of the effect of condom use on HSV-2 acquisition.
METHODS: Data were pooled from 6 prospective studies that measured HSV-2 status at enrollment and over follow-up, and included periodic self-reported condom use and sexual activity. Sexual activity contemporaneous with acquisition was assigned to a case period; earlier sexual activity was assigned to a control period. Conditional logistic regression was used to assess differences in behavior during the case and control periods.
RESULTS: One hundred ninety-one eligible participants acquired HSV-2 during follow-up. This approach detected a 3.6% increase in the odds of HSV-2 acquisition with each unprotected act (odds ratio = 1.036; 95% confidence interval: 1.021-1.052), but no increase in the odds of acquisition associated with protected acts (odds ratio = 1.008; 95% confidence interval: 0.987-1.030).
CONCLUSIONS: This analysis suggests that condoms offer significant protection against HSV-2 transmission.

Entities:  

Mesh:

Year:  2012        PMID: 22504606      PMCID: PMC3334342          DOI: 10.1097/OLQ.0b013e318248aa8a

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  29 in total

Review 1.  Condom use and the prevention of genital herpes acquisition.

Authors:  Corey Casper; Anna Wald
Journal:  Herpes       Date:  2002-04

2.  Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection.

Authors:  R L Ashley; M Eagleton; N Pfeiffer
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population.

Authors:  J Noell; P Rohde; L Ochs; P Yovanoff; M J Alter; S Schmid; J Bullard; C Black
Journal:  Sex Transm Dis       Date:  2001-01       Impact factor: 2.830

4.  Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group.

Authors:  T A Peterman; L S Lin; D R Newman; M L Kamb; G Bolan; J Zenilman; J M Douglas; J Rogers; C K Malotte
Journal:  Sex Transm Dis       Date:  2000-09       Impact factor: 2.830

5.  Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.

Authors:  A Wald; A G Langenberg; K Link; A E Izu; R Ashley; T Warren; S Tyring; J M Douglas; L Corey
Journal:  JAMA       Date:  2001-06-27       Impact factor: 56.272

Review 6.  Should we use a case-crossover design?

Authors:  M Maclure; M A Mittleman
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

7.  Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.

Authors:  H Austin; M Macaluso; A Nahmias; F K Lee; J Kelaghan; M Fleenor; E W Hook
Journal:  Sex Transm Dis       Date:  1999-07       Impact factor: 2.830

8.  Herpes simplex virus type 2 in prisoners, New South Wales, Australia.

Authors:  T Butler; B Donovan; J Taylor; A L Cunningham; A Mindel; M Levy; J Kaldor
Journal:  Int J STD AIDS       Date:  2000-11       Impact factor: 1.359

9.  Utility of behavioral changes as markers of sexually transmitted disease risk reduction in sexually transmitted disease/HIV prevention trials.

Authors:  Steven David Pinkerton; Harrell Warren Chesson; Peter Mark Layde
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

10.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.

Authors:  M L Kamb; M Fishbein; J M Douglas; F Rhodes; J Rogers; G Bolan; J Zenilman; T Hoxworth; C K Malotte; M Iatesta; C Kent; A Lentz; S Graziano; R H Byers; T A Peterman
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

View more
  4 in total

Review 1.  Herpes Genitalis: Diagnosis, Treatment and Prevention.

Authors:  A Sauerbrei
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10-18       Impact factor: 2.915

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 3.  Optimal management of genital herpes: current perspectives.

Authors:  Andreas Sauerbrei
Journal:  Infect Drug Resist       Date:  2016-06-13       Impact factor: 4.003

4.  Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.

Authors:  Amalia S Magaret; Andrew Mujugira; James P Hughes; Jairam Lingappa; Elizabeth A Bukusi; Guy DeBruyn; Sinead Delany-Moretlwe; Kenneth H Fife; Glenda E Gray; Saidi Kapiga; Etienne Karita; Nelly R Mugo; Helen Rees; Allan Ronald; Bellington Vwalika; Edwin Were; Connie Celum; Anna Wald
Journal:  Clin Infect Dis       Date:  2015-11-17       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.